Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus in Early Stage CTCL
NCT01843998Phase 2Withdrawn
- Start
- Feb 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in cutaneous T-cell lymphoma (CTCL). Planned start Feb 2014; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT01843998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843998.